European Economic
and Social Committee
Pharmaceutical package
Background
The pharmaceutical industry is one of the largest and most economically important industries in the European Union, employing around 840 000 people directly and generating three times as much employment indirectly. In 2021, the industry invested an estimated EUR 41 billion in research and innovation.
This opinion from the European Economic and Social Committee covers the proposed revision of EU pharmaceuticals legislation and sets out measures to address antimicrobial resistance in the EU.
Overall, the EESC is very supportive of this long-awaited revamp and backs the European Commission's twin goal of making medicines more affordable and readily available while also ensuring that the industry remains competitive and attracts investment. The measures the EESC suggests embrace this spirit, aiming to maximise benefits for both patients and industry.
Key points
The EESC suggests:
- making more use of joint purchasing of medicines, which can take many shapes, to help ensure access to affordable treatment, which remain an issue;
- setting up a special EU-level fund to ensure access to treatment for all patients in Europe suffering from rare diseases, taking into account disparities in healthcare provision between Member States, such as when statutory health insurance does not cover the entire cost of treatment;
- offering incentives to favour drug manufacturers in the EU and encourage the relocation of production from non-EU countries in order to mitigate dependencies. It also proposes the establishment of a European contingency reserve of medicines of strategic importance.
Additional information
EESC section responsible: Single Market, Production and Consumption (INT)
Opinion type: mandatory consultation
Rapporteur: Martin SCHAFFENRATH (Civil Society Organisations – AT)
References: COM(2023) 190 final COM(2023) 191 final 2023/0125 NLECOM(2023) 191 final 2023/0125 NLECOM(2023) 192 final 2023/0132 CODCOM(2023) 192 final 2023/0132 CODCOM(2023) 193 final 2023/0131 CODCOM(2023) 193 final 2023/0131 COD
Date of adoption by section: 03/10/2023
Result of the vote: 80 votes in favour, none against, with no abstentions.
Contacts
Daniela MARANGONIPress officer
Tel.: + 32 2 546 8422 | Mob: +32 475 99 94 32
email: daniela.marangoni@eesc.europa.eu
Radoslava STEFANKOVA
Policy officer
Tel.: +32 2 546 8188
Recommended for you
YEYS! 2023: De unge ønsker et mere gennemsigtigt, digitalt og forenklet EU
News
Den 23.-24. marts var Det Europæiske Økonomiske og Sociale Udvalg (EØSU) vært for den 14. udgave af arrangement Dit Europa, din mening! (YEYS!), hvor 105 elever fra 35 skoler fra alle 27 EU…
EØSU åbner for ansøgninger til civilsamfundsprisen, som i år har fokus på mental sundhed
News
Civilsamfundsorganisationer, enkeltpersoner og private virksomheder kan nu indstille deres nonprofitprojekter til EØSU's pris til støtte for europæernes mentale trivsel Det Europæiske Økonomiske og…
Gør brug af din stemme i juni 2024: EØSU opfordrer europæerne til at stemme for et forenet og demokratisk Europa
News
Det går tilbage for demokratiet i store dele af verden, misinformationen florerer, og der er stadig større utilfredshed på grund af stigende inflation og truslen om krig, som lurer i baggrunden. Der…
Kunstig intelligens kan fremme behandlingen af sjældne sygdomme
News
På en konference afholdt i Danmark af Det Europæiske Økonomiske og Sociale Udvalg (EØSU) fremhævedes den afgørende rolle, som kunstig intelligens kan spille i udviklingen af nye fremtidsorienterede…
Det danske rådsformandskab vil arbejde for "et stærkt Europa i en verden i forandring"
News
I juli var Det Europæiske Økonomiske og Sociale Udvalgs (EØSU) plenarforsamling vært for en debat om de politiske prioriteter for det nuværende formandskab for Rådet for Den Europæiske Union. De…